These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36857314)

  • 1. Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group.
    Metts J; Xue W; Gao Z; Ermoian R; Bradley JA; Arnold MA; Dasgupta R; Venkatramani R; Walterhouse D
    Cancer; 2023 Jun; 129(11):1735-1743. PubMed ID: 36857314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Raney RB; Walterhouse DO; Meza JL; Andrassy RJ; Breneman JC; Crist WM; Maurer HM; Meyer WH; Parham DM; Anderson JR
    J Clin Oncol; 2011 Apr; 29(10):1312-8. PubMed ID: 21357783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 4. 45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Ermoian RP; Breneman J; Walterhouse DO; Chi YY; Meza J; Anderson J; Hawkins DS; Hayes-Jordan AA; Parham DM; Yock TI; Donaldson SS; Wolden SL
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28548706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.
    Barr EK; Naranjo A; Twist CJ; Tenney SC; Schmidt ML; London WB; Gastier-Foster J; Adkins ES; Mattei P; Handler MH; Matthay KK; Park JR; Maris JM; Desai AV; Cohn SL
    Pediatr Blood Cancer; 2024 Aug; 71(8):e31089. PubMed ID: 38822537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Heske CM; Chi YY; Venkatramani R; Li M; Arnold MA; Dasgupta R; Hiniker SM; Hawkins DS; Mascarenhas L
    Cancer; 2021 Mar; 127(6):946-956. PubMed ID: 33216382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhabdomyosarcoma with isolated lung metastases: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Vasquez JC; Luo LY; Hiniker SM; Rhee DS; Dasgupta R; Chen S; Weigel BJ; Xue W; Venkatramani R; Arndt CA
    Pediatr Blood Cancer; 2023 Jun; 70(6):e30293. PubMed ID: 36916768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low-risk clinical trials: A report from the Children's Oncology Group.
    Aye JM; Xue W; Palmer JD; Walterhouse DO; Arnold MA; Heaton TE; Venkatramani R
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28914. PubMed ID: 33501771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups.
    Minard-Colin V; Walterhouse D; Bisogno G; Martelli H; Anderson J; Rodeberg DA; Ferrari A; Jenney M; Wolden S; De Salvo G; Arndt C; Merks JHM; Gallego S; Schwob D; Haie-Meder C; Bergeron C; Stevens MCG; Oberlin O; Hawkins D;
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27096. PubMed ID: 29781567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 45 GyRBE for group III orbital embryonal rhabdomyosarcoma.
    Indelicato DJ; Rotondo RL; Mailhot Vega RB; Uezono H; Bradfield S; Agarwal V; Hol ML; Bradley JA
    Acta Oncol; 2019 Oct; 58(10):1404-1409. PubMed ID: 31530120
    [No Abstract]   [Full Text] [Related]  

  • 11. Second-line therapy in young patients with relapsed or refractory orbital rhabdomyosarcoma.
    Zloto O; Minard-Colin V; Boutroux H; Brisse HJ; Levy C; Kolb F; Bolle S; Carton M; Helfre S; Orbach D
    Acta Ophthalmol; 2021 May; 99(3):334-341. PubMed ID: 32833335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group.
    Rodeberg DA; Garcia-Henriquez N; Lyden ER; Davicioni E; Parham DM; Skapek SX; Hayes-Jordan AA; Donaldson SS; Brown KL; Triche TJ; Meyer WH; Hawkins DS
    J Clin Oncol; 2011 Apr; 29(10):1304-11. PubMed ID: 21357792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: a report from the Children's Oncology Group.
    Raney B; Huh W; Hawkins D; Hayes-Jordan A; Million L; Rodeberg D; Teot L; Anderson J;
    Pediatr Blood Cancer; 2013 Mar; 60(3):371-6. PubMed ID: 22961750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
    Meza JL; Anderson J; Pappo AS; Meyer WH;
    J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment results for patients with localized, completely resected (Group I) alveolar rhabdomyosarcoma on Intergroup Rhabdomyosarcoma Study Group (IRSG) protocols III and IV, 1984-1997: a report from the Children's Oncology Group.
    Raney RB; Anderson JR; Brown KL; Huh WW; Maurer HM; Meyer WH; Parham DM; Rodeberg DA; Wolden SL; Donaldson SS;
    Pediatr Blood Cancer; 2010 Oct; 55(4):612-6. PubMed ID: 20806360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of patients with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcomas enrolled in phase 2 cooperative group clinical trials: A report from the Children's Oncology Group.
    Oberoi S; Qumseya A; Xue W; Venkatramani R; Weiss AR
    Cancer; 2024 Jul; 130(14):2493-2502. PubMed ID: 38470405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
    Routh JC; Dasgupta R; Chi YY; Shnorhavorian M; Tian J; Walterhouse DO; Breneman J; Wolden SL; Arndt CA; Hawkins DS; Rodeberg DA
    Int J Cancer; 2020 Dec; 147(11):3168-3176. PubMed ID: 32525556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee.
    Rodeberg DA; Anderson JR; Arndt CA; Ferrer FA; Raney RB; Jenney ME; Brecht IB; Koscielniak E; Carli M; Bisogno G; Oberlin O; Rey A; Ullrich F; Stevens MC; Meyer WH
    Int J Cancer; 2011 Mar; 128(5):1232-9. PubMed ID: 20473932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Walterhouse DO; Pappo AS; Meza JL; Breneman JC; Hayes-Jordan A; Parham DM; Cripe TP; Anderson JR; Meyer WH; Hawkins DS
    Cancer; 2017 Jun; 123(12):2368-2375. PubMed ID: 28211936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term evaluation of orbital rhabdomyosarcoma in children.
    Boutroux H; Levy C; Mosseri V; Desjardins L; Plancher C; Helfre S; Freneaux P; Cellier C; Orbach D
    Clin Exp Ophthalmol; 2015; 43(1):12-9. PubMed ID: 24923774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.